Paricalcitol Protects Peritoneal Membrane Function in Encapsulating Peritoneal Sclerosis

---

Atıf İçin Kopyala

Gul C. B., YILDIZ A., AYTAÇ VURUŞKAN B., ÖZ GÜL Ö., ORUÇ A., Aktas N., ...Daha Fazla

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, cilt.25, sa.3, ss.283-288, 2016 (ESCI)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 25 Sayı: 3
• Basım Tarihi: 2016
• Doi Numarası: 10.5262/tndt.2016.1003.12
• Dergi Adı: TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL
• Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
• Sayfa Sayıları: ss.283-288
• Bursa Uludağ Üniversitesi Adresli: Evet

Özet

OBJECTIVE: The most lethal complication of peritoneal dialysis is encapsulating peritoneal sclerosis (EPS), which develops as a result of epithelio-mesenchymal transformation (EMT) and known fibrotic processes. Paricalcitol has previously been shown to inhibit both EMT and fibrosis. We investigated the effect of paricalcitol on EPS.